Hu Yinan
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| The Relationship Between Total Sialic Acid and Superoxide Dismutase and the Diagnosis and Prognosis of Lipoid Pneumonia (NCT06430008) | Hu Yinan | 2024-05-01 |
| Tocilizumab in Refractory ASS-ILD (NCT07662265) | Hu Yinan | 2022-01-01 |
Track Hu Yinan automatically
Every clearance here is in the API, with alerts when new ones post.